Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday.
The pharmaceutical giant reported revenue of $22.3 billion, up 7.9% year-over-year, but lower than the Wall Street projection.
Net earnings of $6.1 billion or $2.32 per share increased by 6.9%, also topped the target that analysts had anticipated.
Most Popular
Key takeaways from Micron’s (MU) first-quarter 2026 results
Micron Technology Inc. (NASDAQ: MU) has reported blockbuster first-quarter results, comfortably beating estimates as strength in data center demand pushed key operating metrics to record levels. Management is now focused
Lennar (LEN) continues to battle a stubbornly difficult housing market
Shares of Lennar Corporation (NYSE: LEN) were down 2% on Thursday. The stock has dropped 17% over the past three months. The homebuilder saw its revenues and profits decline in
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
